Doctor’s Passport

Find your next topic

Explore the current textbook

Available drafts · Clinical review pending
Membership
Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.
Rapid

Ileal pouch surgery and pouchitis

Essential points for quick revision.

Saved on this device
!
Possible pouch leak or pelvic sepsis

Early postoperative fever, tachycardia, escalating pelvic or abdominal pain, ileus, purulent drain output, hypotension or organ dysfunction suggests a leak or infected collection rather than simple pouchitis.

Action: Start ABCDE resuscitation, intravenous access, blood tests including lactate and renal function, blood and drain cultures and locally approved intravenous antibiotics. Call colorectal surgery and anaesthesia urgently and obtain contrast CT when stable enough; drain, divert, repair or re-operate according to physiology and anatomy rather than delaying source control for routine pouchoscopy.

Synopsis

Explain how ileal pouch–anal anastomosis restores intestinal continuity after proctocolectomy, recognise early pelvic sepsis and later inflammatory or mechanical pouch disorders, and investigate and treat a first episode of acute pouchitis without overlooking secondary causes.

  • An ileal pouch–anal anastomosis uses ileum as a reservoir after the colon and rectum are removed; it avoids a permanent stoma but does not restore normal colonic storage.
  • Pouch choice belongs in a high-volume specialist discussion covering stool frequency, urgency, seepage, fertility, sexual and urinary function, pouch failure and the alternative of a permanent ileostomy.
  • Fever, tachycardia, escalating pelvic or abdominal pain, ileus or purulent drain output soon after pouch surgery suggests anastomotic leak or pelvic sepsis and needs urgent CT-led source-control assessment.

Key red flags

After pouch construction, a rising pulse with fever, pelvic pain, ileus or abnormal drain fluid is a leak pattern until imaging and surgical assessment show otherwise; shock or organ dysfunction demands immediate source control.

High pouch output with oliguria, postural symptoms or rising creatinine indicates clinically important dehydration and requires same-day assessment.

A new fistula, deep ulcer, pre-pouch ileitis, obstructive pattern or failure of a correctly delivered acute course requires specialist re-phenotyping.

Investigation priorities

01
Stool culture and Clostridioides difficile assayFirst step

Exclude enteric infection before attributing increased pouch output to idiopathic inflammation.

Management branches

Worked case: a first confirmed acute pouchitis episodeConfirm distribution and infection status before a finite antibiotic course

A 39-year-old weighing 60 kg is three years after ileal pouch–anal anastomosis for ulcerative colitis. Their stable baseline is five stools by day and none at night; over six days this rises to twelve watery stools, two nocturnal episodes, urgency and cramps. Temperature is 37.2°C, pulse 84/min and there is no guarding.

  1. Assess hydration, abdominal and perianal findings and medication exposure. Full blood count and creatinine are normal, CRP is 19 mg/L, and there is no postoperative sepsis pattern requiring emergency CT.
  2. Send stool culture and Clostridioides difficile testing; both are negative. Arrange pouchoscopy because symptoms alone cannot distinguish pouchitis from cuffitis, pre-pouch ileitis or mechanical disease.

Key medicines

Metronidazole 400 mg tablets for confirmed acute pouchitisFor the 60 kg worked patient, give 400 mg orally three times daily with or after food for 14 days: 1200 mg/day equals the trial’s 20 mg/kg/day. This division uses the active 400 mg tablet; the trial abstract verified total daily dose and duration, not exact frequency, and pouchitis use is specialist-selected rather than a licensed product indication.Avoid in nitroimidazole hypersensitivity. Do not drink alcohol during treatment or for 48 hours afterwards. Because the course exceeds 10 days, arrange clinical and laboratory review including leucocyte count and monitor paraesthesia, ataxia, dizziness or seizures. Review severe hepatic disease, warfarin/INR, lithium, disulfiram and ciclosporin interactions.
Ciprofloxacin 500 mg tablets for acute pouchitis when other antibiotics are inappropriateWhen a specialist documents that other commonly recommended antibiotics are inappropriate, give 500 mg orally twice daily for 14 days. With CrCl 30–60 mL/min the selected product permits 250–500 mg every 12 hours; at 30 mL/min or below use 250–500 mg every 24 hours, including after haemodialysis.Do not combine with tizanidine and avoid concurrent corticosteroids because tendon rupture risk increases. Stop at tendon pain, neuropathy, muscle weakness or neuropsychiatric effects. Give oral ciprofloxacin 1–2 hours before or at least 4 hours after iron, calcium, magnesium, aluminium, sucralfate or phosphate binders; do not take it with dairy or mineral-fortified drink alone, and review QT, warfarin and theophylline risks.
Open full textbook Answer 2 questions
Sources and review status7 sources · checked 8 Sept 2026 · clinical review pending
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 8 Sept 2026; clinical approval remains outstanding.

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom